Ultra-Committed
- - - To transform the lives of as many people living with rare diseases as possible, we dedicate ourselves every day to the development and delivery of treatments of rare diseases where none currently exist.
  - - Ultra-Committed
      Learn more
  - Ultra-committed
Research
- - - We develop therapies for rare and ultrarare genetic diseases by exploring an array of drug modalities to select the best treatment strategy for each genetic disease we are studying.
  - - Research
      Learn more
Medicines
Partnerships
Join Our Team
- - - We have built a talented team and a vibrant, people-first culture. We share a passion for helping those living with rare diseases.
  - - Join our team
      Learn More
  - Join Our Team
Newsroom
- - - Access news releases, presentations, and blog posts to follow the latest developments at Ultragenyx.
  - - Newsroom
      Learn More
  - Newsroom
Investors
- - Investor Relations

Committee
composition

Director Name	Audit	Nominating and Corporate Governance	Compensation	Research and Development
Emil D. Kakkis M.D., Ph.D.				member of Research and Development
Amrit Ray M.D., M.B.A.				chairperson of Research and Development
Deborah Dunsire, M.D.			member of Compensation	member of Research and Development
Daniel G. Welch Chairman of the Board		member of Nominating and Corporate Governance	member of Compensation
Matthew K. Fust	chairperson of Audit	member of Nominating and Corporate Governance
Michael Narachi	member of Audit		chairperson of Compensation
Corsee Sanders, Ph.D.	member of Audit			member of Research and Development
Shehnaaz Suliman M.D.		chairperson of Nominating and Corporate Governance	member of Compensation

= Chairperson = Member = Chairman of the Board